"Xbrane Biopharma AB (publ) has been removed from OMX Nordic Small Cap Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.239 SEK | 0.00% | +2.14% | -97.61% |
22/05 | Xbrane Successfully Scale Up Xdivane- Biosimilar Candidate to Opdivo®? | CI |
16/05 | Transcript : Xbrane Biopharma AB, Q1 2024 Earnings Call, May 16, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-97.61% | 3.47Cr | |
+24.74% | 4.75TCr | |
-0.47% | 4.2TCr | |
+43.96% | 4.16TCr | |
+25.40% | 3.04TCr | |
+17.96% | 2.76TCr | |
-4.47% | 2.87TCr | |
+50.73% | 1.47TCr | |
+42.56% | 1.35TCr | |
+1.46% | 1.23TCr |
- Stock Market
- Equities
- XBRANE Stock
- News Xbrane Biopharma AB
- Xbrane Biopharma AB(OM: XBRANE) dropped from OMX Nordic Small Cap Index